Solrød Tandklinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 4.3% 2.3% 2.4% 0.9%  
Credit score (0-100)  0 48 63 63 86  
Credit rating  N/A BBB BBB BBB A  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 372.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 4,373 7,034 8,057 11,488  
EBITDA  0.0 -7.1 1,732 1,110 4,124  
EBIT  0.0 -483 970 273 3,049  
Pre-tax profit (PTP)  0.0 -760.7 650.5 5.6 2,638.4  
Net earnings  0.0 -607.4 502.6 1.6 2,098.0  
Pre-tax profit without non-rec. items  0.0 -761 650 5.6 2,638  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 3,515 4,042 3,466 5,843  
Shareholders equity total  0.0 -567 -64.8 -63.2 2,035  
Interest-bearing liabilities  0.0 5,425 5,695 4,711 4,230  
Balance sheet total (assets)  0.0 6,945 6,765 6,062 8,307  

Net Debt  0.0 4,746 5,693 4,675 4,191  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 4,373 7,034 8,057 11,488  
Gross profit growth  0.0% 0.0% 60.9% 14.5% 42.6%  
Employees  0 0 10 13 13  
Employee growth %  0.0% 0.0% 0.0% 30.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 6,945 6,765 6,062 8,307  
Balance sheet change%  0.0% 0.0% -2.6% -10.4% 37.0%  
Added value  0.0 -7.1 1,732.1 1,034.8 4,124.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 5,217 -477 -1,655 1,059  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% -11.0% 13.8% 3.4% 26.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -6.4% 13.5% 4.3% 42.3%  
ROI %  0.0% -8.6% 17.1% 5.3% 53.6%  
ROE %  0.0% -8.7% 7.3% 0.0% 51.8%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% -7.6% -1.0% -1.1% 25.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -66,492.4% 328.7% 421.1% 101.6%  
Gearing %  0.0% -956.1% -8,791.7% -7,455.3% 207.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 10.3% 5.8% 5.2% 9.3%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.4 0.2 0.2 0.2  
Current Ratio  0.0 0.4 0.2 0.2 0.3  
Cash and cash equivalent  0.0 679.2 1.8 36.2 38.5  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -1,645.8 -2,484.1 -3,961.7 -1,983.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 173 80 317  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 173 85 317  
EBIT / employee  0 0 97 21 235  
Net earnings / employee  0 0 50 0 161